Greenstone Biosciences, Inc.
Palo Alto, CA
- UEI
- ETE2HHEYPAV7
- CAGE
- 9CZA7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3160 Porter Dr Suite 200, Palo Alto, CA 94304, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Small molecule drug discovery for cardiac fibrosis using AI/ML and ipsc-derived organoids - duchenne muscular… | National Heart Lung and Blood Institute | $625,968 | |
| Drug discovery for duchenne muscular dystrophy using AI/ML and ipsc-derived organoids | Defense Health Agency | $490,000 | |
| AI/ML and ipsc-derived organoids for myotonic dystrophy drug discovery - project summary/abstract drug discovery for… | National Center for Advancing Translational Sciences | $495,000 | |
| Elucidating mechanistic pathways of lmna cardiomyopathy and novel therapeutic compounds | Defense Health Agency | $1,348,274 | |
| Ethnically diverse ipsc-cardiomyocyte panel for pharmacogenomics and drug safety testing - project summary… | National Heart Lung and Blood Institute | $2,741,939 |
About Greenstone Biosciences, Inc.
Greenstone Biosciences, Inc. is a biotechnology company located in Palo Alto, California, specializing in advanced drug discovery and development technologies. The company focuses on leveraging cutting-edge techniques such as induced pluripotent stem cell (iPSC) technology, artificial intelligence, and machine learning to accelerate pharmaceutical research, particularly in the realm of rare genetic disorders and precision medicine. Their core expertise lies in computational biology, genomics, and developing innovative platforms for pharmacogenomic research that can potentially transform drug development processes for complex genetic conditions.
The company has secured multiple significant federal grant awards from both defense and civilian agencies, including the Defense Health Agency and the National Center for Advancing Translational Sciences. These grants, ranging from $110,000 to $1,348,274, have supported research in critical areas such as drug discovery for Duchenne muscular dystrophy, myotonic dystrophy type 1, and LMNA cardiomyopathy. Specifically, Greenstone Biosciences has developed advanced research platforms that utilize iPSC-derived organoids and AI/ML algorithms to identify novel therapeutic compounds, assess drug safety and efficacy, and explore mechanistic pathways of genetic disorders. Their work aims to create more efficient drug discovery processes, with a particular focus on rare diseases, by developing innovative screening methods that can replace, reduce, or refine traditional clinical trials, ultimately providing more personalized and precise medical treatments.
Quick answers
What is Greenstone Biosciences, Inc.'s UEI?
Greenstone Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is ETE2HHEYPAV7.
What is Greenstone Biosciences, Inc.'s CAGE code?
Greenstone Biosciences, Inc.'s CAGE code is 9CZA7.
What is Greenstone Biosciences, Inc.'s primary NAICS code?
Greenstone Biosciences, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Greenstone Biosciences, Inc. located?
Greenstone Biosciences, Inc.'s physical address in SAM.gov is 3160 Porter Dr Suite 200, Palo Alto, CA 94304, USA.
Is Greenstone Biosciences, Inc. registered in SAM.gov?
Yes. Greenstone Biosciences, Inc.'s SAM.gov registration is active through May 14, 2027.
What is Greenstone Biosciences, Inc.'s most recent federal award?
Greenstone Biosciences, Inc.'s most recent federal grant award is Small molecule drug discovery for cardiac fibrosis using AI/ML and ipsc-derived organoids - duchenne muscular… (R61HL179715), from National Heart Lung and Blood Institute, on August 1, 2026.
On GovTribe
See Greenstone Biosciences, Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors